Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Mehr anzeigen
REDWOOD CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...
Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.98 | 17.3451327434 | 5.65 | 6.64 | 5.57 | 215477 | 5.91710229 | CS |
| 4 | 0.39 | 6.25 | 6.24 | 7.27 | 5.57 | 226236 | 6.30734963 | CS |
| 12 | 0.13 | 2 | 6.5 | 7.27 | 5.57 | 219543 | 6.35721945 | CS |
| 26 | 0.62 | 10.3161397671 | 6.01 | 8.79 | 5.46 | 239548 | 6.78486761 | CS |
| 52 | -7.85 | -54.2127071823 | 14.48 | 14.92 | 5.46 | 367703 | 8.07807873 | CS |
| 156 | -19.25 | -74.3817619784 | 25.88 | 29.25 | 4.07 | 388617 | 11.99126183 | CS |
| 260 | -31.37 | -82.5526315789 | 38 | 69.4779 | 4.07 | 373166 | 20.43850977 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
